Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier

QR Code

Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier

Evidence in support of links between type-2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) has increased considerably in recent years. AD pathological hallmarks include the accumulation of extracellular amyloid-ß (Aß) and intracellular hyperphosphorylated tau in the brain, which are hypo...

Full description

Bibliographic Details
Main Authors:	Asih, P., Tegg, M., Sohrabi, H., Carruthers, M., Gandy, S., Saad, F., Verdile, Giuseppe, Ittner, L., Martins, R.
Format:	Journal Article
Published:	IOS Press 2017
Online Access:	http://hdl.handle.net/20.500.11937/56666

Similar Items

The impact of luteinizing hormone and testosterone on beta amyloid (Aß) accumulation: Animal and human clinical studies
by: Verdile, Giuseppe, et al.
Published: (2015)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men
by: Wahjoepramono, E., et al.
Published: (2016)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism
by: Verdile, Giuseppe, et al.
Published: (2009)

Assessing genetic overlap of Alzheimer’s disease with type 2 diabetes
by: Adewuyi, Emmanuel, et al.
Published: (2025)

Amyloid-ß and islet amyloid pathologies link Alzheimer disease and type 2 diabetes in a transgenic model.
by: Wijesekara, N., et al.
Published: (2017)

Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)

Testosterone replacement therapy in older male subjective memory complainers: Double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety
by: Asih, P., et al.
Published: (2015)

The role of type 2 diabetes in neurodegeneration
by: Verdile, Giuseppe, et al.
Published: (2015)

Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction
by: Foster, Jonathan, et al.
Published: (2008)

Distinct Effects of Testosterone on Plasma and Cerebrospinal Fluid Amyloid-ß Levels
by: Wahjoepramono, E., et al.
Published: (2008)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-ß, Amylin, and Tau Proteins
by: Bharadwaj, Prashant, et al.
Published: (2017)

Zebrafish as a tool in Alzheimer's disease research
by: Newman, M., et al.
Published: (2011)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms
by: Barron, A., et al.
Published: (2006)

Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
by: Goozee, K., et al.
Published: (2015)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

Reproductive Hormones Modulate Oxidative Stress in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2006)

Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)

Immunization in Alzheimer’s disease: Naïve hope or realistic clinical potential?
by: Foster, Jonathan, et al.
Published: (2009)

Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)

Effect of chronic hCG administration on Alzheimer's-related cognition and Aß accumulation in PS1KI mice
by: Barron, A., et al.
Published: (2010)

Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)

The dynamics of CD147 in Alzheimer's disease development and pathology
by: Kanyenda, L., et al.
Published: (2011)

Enhancing Cognitive Functioning in Healthly Older Adults: a Systematic Review of the Clinical Significance of Commercially Available Computerized Cognitive Training in Preventing Cognitive Decline
by: Shah, T., et al.
Published: (2017)

Inflammation in Alzheimer's Disease, and Prevention with Antioxidants and Phenolic Compounds – What Are the Most Promising Candidates?
by: Sharman, M., et al.
Published: (2019)

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
by: Bharadwaj, P., et al.
Published: (2013)

The structure and function of Alzheimer's gamma secretase enzyme complex
by: Krishnaswamy, S., et al.
Published: (2009)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

Can testosterone replacement decrease the memory problem of old age?
by: Lim, David, et al.
Published: (2003)

Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease
by: Gnjec, A., et al.
Published: (2008)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2015)

Predicting memory decline as a risk factor for Alzheimer’s disease in older post-menopausal women: quod erat demonstrandum?
by: Rodrigues, M., et al.
Published: (2010)

Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of ?-secretase activity
by: Nik, S., et al.
Published: (2015)

Dysregulation of neuronal iron homeostasis as an alternative unifying effect of mutations causing familial Alzheimer's disease
by: Lumsden, A., et al.
Published: (2018)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

Erratum: Clearance mechanisms of Alzheimer's amyloid-? peptide: Implications for therapeutic design and diagnostic tests (Molecular Psychiatry (2009) 14 (469-486) DOI: 10.1038/mp.2008.96)
by: Bates, K., et al.
Published: (2009)